Active Ingredient History
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Afibrinogenemia (approved 2009)
Afibrinogenemia (Phase 4)
Aneurysm (Phase 4)
Aortic Aneurysm (Phase 2)
Aortic Diseases (Phase 2)
Bleeding Time (Phase 4)
Blood Coagulation (Phase 4)
Blood Coagulation Disorders (Phase 4)
Blood Loss, Surgical (Phase 3)
Blood Platelet Disorders (Phase 2)
Brain Injuries, Traumatic (Phase 1/Phase 2)
Bronchiectasis (Phase 2/Phase 3)
Cardiac Surgical Procedures (Phase 2)
Coronary Artery Disease (Phase 2)
Deficiency Diseases (Phase 4)
Fibrin (Phase 4)
Fibrinogen (Phase 2)
General Surgery (Phase 4)
Heart Defects, Congenital (Phase 4)
Heart Diseases (Phase 3)
Heart Valve Diseases (Phase 2)
Hematologic Diseases (Phase 2)
Hemorrhage (Phase 4)
Hemostasis (Phase 4)
Intraoperative Complications (Phase 3)
Liver Diseases (Phase 3)
Lung Diseases (Phase 3)
Multiple Trauma (Phase 1/Phase 2)
Pancreatic Neoplasms (Phase 4)
Pediatrics (Phase 4)
Postoperative Hemorrhage (Phase 3)
Postpartum Hemorrhage (Phase 4)
Pterygium (Phase 3)
Scoliosis (Phase 3)
Sepsis (Phase 3)
Shock, Hemorrhagic (Phase 3)
Shock, Septic (Phase 3)
Thrombosis (Phase 4)
Tissue Adhesions (Phase 2)
Transfusion Reaction (Phase 2)
Transfusion-Related Acute Lung Injury (Phase 2)
Traumatology (Phase 4)
Wounds and Injuries (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
